Allianz Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-362,625
Closed -$16.2M 2669
2021
Q2
$16.2M Buy
362,625
+71,035
+24% +$3.29M 0.01% 697
2021
Q1
$14.6M Buy
291,590
+180,784
+163% +$12.3M 0.01% 715
2020
Q4
$9.91M Buy
110,806
+12,575
+13% +$1.06M 0.01% 843
2020
Q3
$7.5M Buy
+98,231
New +$6.24M 0.01% 856

Other funds holding CELL

Allianz Asset Management's CELL Position: Q3 2021 in Review

Allianz Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 362,625 shares — an estimated $16.2M sold.

Allianz Asset Management first reported a position in CELL in Q3 2020 and held it in 4 quarters. The position peaked at $16.2M in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Allianz Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Allianz Asset Management sold 362,625 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $16.2M.
  • Allianz Asset Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Allianz Asset Management's PhenomeX Inc. Common Stock position peaked at $16.2M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.